Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health, according to a study in the Journal of the National Cancer Institute. Read more and read the study abstract.
Experimental drug may stop cancer-induced cachexia
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
